Chronic Kidney Disease May Be Overestimated in the Elderly
Using a fixed estimated glomerular filtration rate threshold rather than an age-adapted definition may overestimate the burden of CKD
Chronic Kidney Disease
Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
Korsuva Approved for Chronic Kidney Disease-Associated Pruritus
The approval was based on data from the pivotal phase 3 KALM-1 and KALM-2 trials, as well as data from an additional 32 clinical studies.
New Drug Product: Kerendia
This slideshow show drug information for Kerendia. Click here for the complete Kerendia monograph.
Race-Free Equations for Glomerular Filtration Rate Compared
eGFRcys resulted in smallest change in CKD prevalence among Black adults compared with race-blended, race-removed equations
FDA Wants Another Study Before Deciding on Tenapanor Approval
Tenapanor inhibits the sodium/hydrogen exchanger 3 to control serum phosphorus in adults with CKD on dialysis.
Dapagliflozin Safe, Effective in Advanced Chronic Kidney Disease
Dapagliflozin’s benefits among patients with stage 4 CKD were consistent with those observed in the larger DAPA-CKD cohort with stage 2-3 CKD.
Tenapanor Reduces Phosphate Binder Pill Burden in Hemodialysis
Unlike phosphate binders, tenapanor decreases paracellular phosphate absorption in the intestine.
Patiromer Prolongs Spironolactone Use Regardless of Diabetes Status
Patient with and without diabetes who received patiromer were more likely to remain on spironolactone at 12 weeks compared with those who received placebo, a subgroup analysis of the AMBER trial showed.
Generic Version of Feraheme Now Available
The first generic version of Feraheme (ferumoxytol injection) has been made available by Sandoz.
